We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$907M
AUM Growth
+$56.8M
Cap. Flow
+$38.8M
Cap. Flow %
4.28%
Top 10 Hldgs %
59.97%
Holding
285
New
20
Increased
122
Reduced
33
Closed
27

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$8.82M
2
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
+$8.7M
3
IBM icon
IBM
IBM
+$7.38M
4
RNF
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
+$2.6M
5
POT
Potash Corp Of Saskatchewan
POT
+$1.87M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.07M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.02M
3
CSCO icon
Cisco
CSCO
+$942K
4
CMG icon
Chipotle Mexican Grill
CMG
+$915K
5
AAPL icon
Apple
AAPL
+$832K

Sector Composition

Rank Sector Weight
1 Healthcare 39%
2 Energy 20.65%
3 Miscellaneous 14.69%
4 Utilities 5.03%
5 Communication Services 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPC icon
201
Marathon Petroleum
MPC
$117B
$101K 0.01%
2,200
– –
OLN icon
202
Olin
OLN
$1.97B
$101K 0.01%
3,512
+9
+0.3% +$224
ABBV icon
203
AbbVie
ABBV
$465B
$95K 0.01%
1,800
– –
VNR
204
DELISTED
Vanguard Natural Resources, LLC
VNR
$93K 0.01%
3,152
+47
+2% +$1.33K
INDB icon
205
Independent Bank
INDB
$3.95B
$92K 0.01%
2,360
– –
PWE
206
DELISTED
Penn West Energy Petroleum Ltd
PWE
$92K 0.01%
11,008
+51
+0.5% +$489
MDT icon
207
Medtronic
MDT
$121B
$87K 0.01%
1,508
+602
+66% +$34.1K
ABT icon
208
Abbott
ABT
$178B
$86K 0.01%
2,250
– –
CST
209
DELISTED
CST Brands, Inc.
CST
$84K 0.01%
2,282
+5
+0.2% +$164
WMB icon
210
Williams Companies
WMB
$87.6B
$83K 0.01%
2,154
– –
MON
211
DELISTED
Monsanto Co
MON
$83K 0.01%
715
– –
BIP icon
212
Brookfield Infrastructure Partners
BIP
$16.5B
$81K 0.01%
5,234
-456
-8% -$6.96K
PG icon
213
Procter & Gamble
PG
$343B
$81K 0.01%
1,000
-2,410
-71% -$196K
NOV icon
214
NOV
NOV
$7.45B
$80K 0.01%
1,109
– –
MRO
215
DELISTED
Marathon Oil Corporation
MRO
$79K 0.01%
2,250
– –
GMLP
216
DELISTED
Golar LNG Partners LP
GMLP
$73K 0.01%
2,397
+34
+1% +$1.05K
UNG icon
217
United States Natural Gas Fund
UNG
$571M
$66K 0.01%
+200
New +$61.5K
XCO
218
DELISTED
Exco Resources
XCO
$66K 0.01%
834
– –
ANDV
219
DELISTED
Andeavor
ANDV
$65K 0.01%
1,118
+398
+55% +$20.7K
MMLP icon
220
Martin Midstream Partners
MMLP
$88.8M
$58K 0.01%
1,346
+23
+2% +$1.04K
AON icon
221
Aon
AON
$64.2B
$57K 0.01%
682
– –
ANDX
222
DELISTED
Andeavor Logistics LP
ANDX
$53K 0.01%
1,020
+10
+1% +$530
CB icon
223
Chubb
CB
$132B
$52K 0.01%
500
– –
YUM icon
224
Yum! Brands
YUM
$38.2B
$50K 0.01%
926
– –
CAH icon
225
Cardinal Health
CAH
$54.4B
$43K ﹤0.01%
644
– –
7 8
9
10 11

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $3.3B AUM 16.21% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Bollard Group's Q4 2013 Portfolio in Review

As of Q4 2013, Bollard Group held 285 positions worth $907M, up 6.7% from $850M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Bollard Group deployed $38.8M of net new capital in Q4 2013, opening 20 new positions and adding to 122 existing holdings. Its largest new stake was Potash Corp Of Saskatchewan: 58,594 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 40% a quarter earlier, followed by Energy and Miscellaneous.

On the sell side, the largest reduction was Pfizer, an estimated $1.07M trimmed.

  • Bollard Group's largest Q4 2013 buy was Potash Corp Of Saskatchewan: 58,594 shares worth $1.93M.
  • Bollard Group added most to Boston Scientific in Q4 2013, an estimated $8.82M increase.
  • Bollard Group's biggest Q4 2013 reduction was Pfizer, cutting an estimated $1.07M.
  • Bollard Group fully exited Alphabet (Google) Class C in Q4 2013, selling an estimated $1.02M.
  • Bollard Group's ten largest holdings make up 60% of its $907M portfolio in Q4 2013.
  • Bollard Group opened 20 new positions and closed 27 in Q4 2013.
  • Bollard Group's portfolio value rose 6.7% quarter-over-quarter to $907M.

Based on Bollard Group's 13F filing for Q4 2013, filed 13 Feb 2014.